Developer docs
API playgroundTry for free, no card

Search company profiles

Institut Pasteur du Cambodge

Full company profile

uuid02lwfgv

Namestring
Institut Pasteur du Cambodge
Legal namestring
Institut Pasteur du Cambodge
Websiteurl
pasteur-kh.org
Company typeenum
Private
Founded yearint
1953
Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersPhnom Penh, Cambodia
HQ citystring
Phnom Penh
HQ countrystring
Cambodia
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical diagnostic services, infectious disease research, vaccination center services, rabies prevention programs, public health surveillance
Industry4 codes
1Public Health Laboratories & Diagnostic Oversight
CodeBPAIAJAFPrimaryYes
2Vaccine Clinical Development & Regulatory Affairs
CodeHLAIAEAMPrimaryNo
3Vaccine R&D, Clinical/Field Trials & Regulatory Affairs
CodeHLAMAKAMPrimaryNo
4Clinical Development & Regulatory for Vaccines (trials, pharmacovigilance, lot release)
CodeHLAAAEAKPrimaryNo
NAICS code4 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Medical Diagnostic Laboratory Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Medical Laboratory Testing Services
TypeTransaction Fee
Description

Fee-for-service medical biology testing offered to public/private hospitals, clinics, NGOs, and individual patients through the accredited Medical Biology Laboratory providing approximately 150-170 different diagnostic tests

pasteur-kh.org
2International Vaccination Center
TypeTransaction Fee
Description

Vaccination services offering pediatric and adult vaccines including those of the national vaccination program, with appropriate cold chain management and quality control

pasteur-kh.org
3Food and Water Safety Testing
TypeTransaction Fee
Description

Laboratory of Environment and Food Safety (LEFS) provides microbiological testing services for food and water safety

pasteur-kh.org
4Rabies Prevention Services
TypeTransaction Fee
Description

Post-exposure prophylaxis and rabies serology services for pets and humans

pasteur-kh.org
5Research Grants and Public Funding
TypeProfessional Services
Description

Non-profit institution supported by grants, public funding, and partnerships with international organizations for research activities in infectious disease surveillance and control

pasteur-kh.org
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Institut Pasteur du Cambodge operates as a non-profit research institution delivering fee-for-service medical biology laboratory testing, international vaccination services, food and water safety analysis, rabies post-exposure prophylaxis, calibration services, and HIV voluntary counseling and testing. It also conducts infectious disease research across six research units (virology, immunology, malaria, entomology, epidemiology and public health, and antimicrobial resistance), serving individual patients, hospitals, NGOs, and the Royal Government of Cambodia.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 500,000+ COVID-19 RT-PCR tests performed during pandemic
+4 more records
Product overview1 text field

Institut Pasteur du Cambodge is a Cambodian non-profit research institution that operates both service-oriented laboratory products and research units. The service portfolio includes six core offerings: the Medical Biology Laboratory (accredited to ISO 15189, providing 150-170 diagnostic tests), the International Vaccination Center (pediatric and adult vaccines), the Laboratory of Environment and Food Safety (ISO 17025 accredited testing), the Rabies Prevention Centers (providing post-exposure prophylaxis to over 175,000 individuals), the Calibration Laboratory (ISO/IEC 17025:2017 accredited), and the Voluntary Counseling & HIV Testing Center. Supporting these services are six research units focused on virology, immunology, malaria research, medical and veterinary entomology, epidemiology and public health, antimicrobial resistance, and bioinformatics and AI applications. The institution functions as an integrated research and public health service organization rather than a commercial product company.

Product and service6 records
1Medical Biology Laboratory (MBL)
CategoryMedical diagnostic laboratory services
2International Vaccination Center
CategoryVaccination and preventive health services
3Laboratory of Environment and Food Safety (LEFS)
CategoryFood, water and environmental testing services
4Rabies Prevention Centers
CategoryRabies prevention and post-exposure prophylaxis services
5Calibration Laboratory
CategoryCalibration and metrology services
6Voluntary Counseling & HIV Testing Center
CategoryHIV counseling and testing services
Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
1Sarawak Infectious Disease Centre (SIDC), Malaysia
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2026-03-19
Description

Strategic partnership formalized through the signing of a Memorandum of Understanding (MoU) on 19 March 2026, marking an important milestone in shared commitment to addressing infectious diseases.

pasteur-kh.org
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-07-20
Description

MoU signed under honor of Prof. André SPIEGEL, Director of IPC and H.E. Prof. Dr. SABO Ojano, President of IU to strengthen academic and research collaboration.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on1992-01-01
Description

IPC operates under a convention signed with the Royal Government of Cambodia and Institut Pasteur (Paris, France) in 1992 and renewed in 2013. Under this convention, IPC operates under the auspice of both the Cambodian Ministry of Health and Institut Pasteur (Paris, France) on scientific and technical levels.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

IPC is a member of the Pasteur Network, which brings together more than 30 institutes present on five continents. It shares Pasteurian values and the ethical charter to which Pasteur Institutes are bound.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Delegation from Kirby Institute visited IPC Medical Biology Laboratory and Virology Unit, led by Prof. John Kaldor and Dr. Dorothy, for collaboration discussions.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

TZW is part of the broader consortium behind the OH4AM project, contributing expertise to strengthen antimicrobial resistance surveillance partnerships in Cambodia.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

WHO designated IPC as International Reference Laboratory for COVID-19 and IPC participates in WHO surveillance networks.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

UNICEF represented at IPC Annual Liaison Council as invited partner.

9French Development Agency (AFD)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

AFD represented at IPC Annual Liaison Council as invited partner.

pasteur-kh.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

IRD partners with IPC on research initiatives including One Health approach projects and international collaborations.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Medical delegation from Sanofi Pasteur (Lyon, France) visited IPC in February 2020 for collaboration discussions.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Joint international double-degree Master's program in Infectious Diseases offered in partnership with Université Paris-Saclay and University of Health Sciences.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership for international double-degree Master's program in Infectious Diseases; IPC delegation visits UHS to meet Cambodian students.

14French National Research Institute for Sustainable Development (IRD)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborative research on climate change effects on dengue vector densities in Southeast Asia.

pasteur-kh.org
15French Agricultural Research Centre for International Development (Cirad)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborative research on climate change effects on dengue vector densities in Southeast Asia.

pasteur-kh.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Regional Pasteur Network collaboration on dengue research and climate change impact studies.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Calmette Hospital represented at IPC Annual Liaison Council as invited partner.

18Kantha Bopha Hospital
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Kantha Bopha Hospital represented at IPC Annual Liaison Council as invited partner.

pasteur-kh.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

NIPH collaborated with IPC during COVID-19 pandemic for sample analysis and case identification.

20Centre for Malaria Control (CNM)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

CNM represented at IPC Annual Liaison Council as invited partner for malaria research collaboration.

pasteur-kh.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pasteur Network institute in Senegal with strong vaccine manufacturing ambitions (MADIBA project) alongside diagnostic and research services. Comparable Pasteur governance model and One Health focus.

TypeEmerging player
Description

Cambodia's domestic public health agency, which collaborated directly with IPC during the COVID-19 pandemic for sample analysis. Adjacent in public health laboratory mission within the same geography.

TypeDirect peer
Description

Thailand-based tropical medicine research unit with deep infectious disease research, clinical trials, and diagnostics. Directly comparable in regional infectious disease research and public health laboratory mandate in Southeast Asia.

TypeDirect peer
Description

Pasteur Network institute in a similarly resource-constrained developing country, operating medical biology labs, vaccination centers, and outbreak response. Directly comparable in scope, funding model, and service mix.

Description

Global non-profit focused on diagnostic access in low- and middle-income countries. Operates in the same infectious disease diagnostics ecosystem and frequently partners with Pasteur Network institutes on capacity building and surveillance programs.

TypeBroad incumbent
Description

Global leader in tropical medicine and public health research, with comparable infectious disease and epidemiology research scope. Larger and broader, but overlapping mandate in global health research and training.

TypeRegional player
Description

Indonesian infectious disease and molecular biology research institute. Comparable in regional infectious disease research, pathogen genomics, and tropical disease focus, though serving a different national market.

TypeDirect peer
Description

Sister Pasteur Network institute in neighboring Laos, with a near-identical mandate of infectious disease research, public health laboratory services, and vaccination. Closest geographic and operational peer to IPC.

TypeRegional player
Description

Phnom Penh-based hospital providing medical services and training in Cambodia. Adjacent peer in domestic Cambodian healthcare delivery, with overlapping referral and laboratory relationships with IPC.

10Institut Pasteur (Paris)
TypeBroad incumbent
Description

Parent and headquarters of the Pasteur Network. Operates a much larger research portfolio globally, including vaccine R&D, but shares the Pasteurian values, ethical charter, and scientific oversight framework that governs IPC.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Institut Pasteur du Cambodge

Medical Diagnostic Laboratory Servicespasteur-kh.org

Institut Pasteur du Cambodge firmographics

Firmographics
Name
Institut Pasteur du Cambodge
Legal name
Institut Pasteur du Cambodge
Website
https://pasteur-kh.org
Company type
Private
Founded year
1953
Operating status
Operating
Ownership category
akta.pro rank

Institut Pasteur du Cambodge industry classification

Industry
Product category
Medical Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Public Health Laboratories & Diagnostic Oversight (BPAIAJAF)
akta.pro secondary industries
Vaccine Clinical Development & Regulatory Affairs (HLAIAEAM), Vaccine R&D, Clinical/Field Trials & Regulatory Affairs (HLAMAKAM), Clinical Development & Regulatory for Vaccines (trials, pharmacovigilance, lot release) (HLAAAEAK)

Keywords

  • Medical diagnostic services
  • Infectious disease research
  • Vaccination center services
  • Rabies prevention programs
  • Public health surveillance

Where Institut Pasteur du Cambodge is headquartered

Location

Headquarters

HQ city
Phnom Penh
HQ country
Cambodia
HQ region
Asia

Offices3 records

Markets served

Institut Pasteur du Cambodge business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Medical Laboratory Testing Services: Fee-for-service medical biology testing offered to public/private hospitals, clinics, NGOs, and individual patients through the accredited Medical Biology Laboratory providing approximately 150-170 different diagnostic tests
  2. International Vaccination Center: Vaccination services offering pediatric and adult vaccines including those of the national vaccination program, with appropriate cold chain management and quality control
  3. Food and Water Safety Testing: Laboratory of Environment and Food Safety (LEFS) provides microbiological testing services for food and water safety
  4. Rabies Prevention Services: Post-exposure prophylaxis and rabies serology services for pets and humans
  5. Research Grants and Public Funding: Non-profit institution supported by grants, public funding, and partnerships with international organizations for research activities in infectious disease surveillance and control

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Institut Pasteur du Cambodge product offering

Product offering

Core offering

Institut Pasteur du Cambodge operates as a non-profit research institution delivering fee-for-service medical biology laboratory testing, international vaccination services, food and water safety analysis, rabies post-exposure prophylaxis, calibration services, and HIV voluntary counseling and testing. It also conducts infectious disease research across six research units (virology, immunology, malaria, entomology, epidemiology and public health, and antimicrobial resistance), serving individual patients, hospitals, NGOs, and the Royal Government of Cambodia.

Product overview

Institut Pasteur du Cambodge is a Cambodian non-profit research institution that operates both service-oriented laboratory products and research units. The service portfolio includes six core offerings: the Medical Biology Laboratory (accredited to ISO 15189, providing 150-170 diagnostic tests), the International Vaccination Center (pediatric and adult vaccines), the Laboratory of Environment and Food Safety (ISO 17025 accredited testing), the Rabies Prevention Centers (providing post-exposure prophylaxis to over 175,000 individuals), the Calibration Laboratory (ISO/IEC 17025:2017 accredited), and the Voluntary Counseling & HIV Testing Center. Supporting these services are six research units focused on virology, immunology, malaria research, medical and veterinary entomology, epidemiology and public health, antimicrobial resistance, and bioinformatics and AI applications. The institution functions as an integrated research and public health service organization rather than a commercial product company.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Biology Laboratory (MBL)
  • International Vaccination Center
  • Laboratory of Environment and Food Safety (LEFS)
  • Rabies Prevention Centers
  • Calibration Laboratory
  • Voluntary Counseling & HIV Testing Center

Quantifiable outcome

  • 500,000+ COVID-19 RT-PCR tests performed during pandemic
  • +4 more outcomes

Companies that use Institut Pasteur du Cambodge

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Institut Pasteur du Cambodge technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Institut Pasteur du Cambodge partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered strategic, minor and core.

  • Sarawak Infectious Disease Centre (SIDC), MalaysiastrategicStrategic or Co-development Partner · 19 March 2026Strategic partnership formalized through the signing of a Memorandum of Understanding (MoU) on 19 March 2026, marking an important milestone in shared commitment to addressing infectious diseases.
  • International University (IU), CambodiaminorStrategic or Co-development Partner · 20 July 2023MoU signed under honor of Prof. André SPIEGEL, Director of IPC and H.E. Prof. Dr. SABO Ojano, President of IU to strengthen academic and research collaboration.
  • Institut Pasteur (Paris, France)coreStrategic or Co-development Partner · 1 January 1992IPC operates under a convention signed with the Royal Government of Cambodia and Institut Pasteur (Paris, France) in 1992 and renewed in 2013. Under this convention, IPC operates under the auspice of both the Cambodian Ministry of Health and Institut Pasteur (Paris, France) on scientific and technical levels.
  • Pasteur NetworkcoreStrategic or Co-development PartnerIPC is a member of the Pasteur Network, which brings together more than 30 institutes present on five continents. It shares Pasteurian values and the ethical charter to which Pasteur Institutes are bound.
  • Kirby Institute, University of New South Wales (UNSW)minorStrategic or Co-development PartnerDelegation from Kirby Institute visited IPC Medical Biology Laboratory and Virology Unit, led by Prof. John Kaldor and Dr. Dorothy, for collaboration discussions.
  • TZW: DVGW-Technologiezentrum Wasser (German Water Centre)minorStrategic or Co-development PartnerTZW is part of the broader consortium behind the OH4AM project, contributing expertise to strengthen antimicrobial resistance surveillance partnerships in Cambodia.
  • World Health Organization (WHO)coreStrategic or Co-development PartnerWHO designated IPC as International Reference Laboratory for COVID-19 and IPC participates in WHO surveillance networks.
  • UNICEFminorStrategic or Co-development PartnerUNICEF represented at IPC Annual Liaison Council as invited partner.
  • French Development Agency (AFD)minorStrategic or Co-development PartnerAFD represented at IPC Annual Liaison Council as invited partner.
  • Institut de Recherche pour le Développement (IRD)minorStrategic or Co-development PartnerIRD partners with IPC on research initiatives including One Health approach projects and international collaborations.
  • Sanofi PasteurminorStrategic or Co-development PartnerMedical delegation from Sanofi Pasteur (Lyon, France) visited IPC in February 2020 for collaboration discussions.
  • Université Paris-SaclayminorStrategic or Co-development PartnerJoint international double-degree Master's program in Infectious Diseases offered in partnership with Université Paris-Saclay and University of Health Sciences.
  • University of Health Sciences (UHS), CambodiaminorStrategic or Co-development PartnerPartnership for international double-degree Master's program in Infectious Diseases; IPC delegation visits UHS to meet Cambodian students.
  • French National Research Institute for Sustainable Development (IRD)minorStrategic or Co-development PartnerCollaborative research on climate change effects on dengue vector densities in Southeast Asia.
  • French Agricultural Research Centre for International Development (Cirad)minorStrategic or Co-development PartnerCollaborative research on climate change effects on dengue vector densities in Southeast Asia.
  • Institut Pasteur du LaosminorStrategic or Co-development PartnerRegional Pasteur Network collaboration on dengue research and climate change impact studies.
  • Calmette HospitalminorStrategic or Co-development PartnerCalmette Hospital represented at IPC Annual Liaison Council as invited partner.
  • Kantha Bopha HospitalminorStrategic or Co-development PartnerKantha Bopha Hospital represented at IPC Annual Liaison Council as invited partner.
  • National Institute of Public Health (NIPH)minorStrategic or Co-development PartnerNIPH collaborated with IPC during COVID-19 pandemic for sample analysis and case identification.
  • Centre for Malaria Control (CNM)minorStrategic or Co-development PartnerCNM represented at IPC Annual Liaison Council as invited partner for malaria research collaboration.

Scale indicators12 records

Recent moves6 records

Expansion highlights7 records

Institut Pasteur du Cambodge competitors and assessment

Company assessment

Direct peers

  • Institut Pasteur de Dakar: Pasteur Network institute in Senegal with strong vaccine manufacturing ambitions (MADIBA project) alongside diagnostic and research services. Comparable Pasteur governance model and One Health focus.
  • Mahidol Oxford Tropical Medicine Research Unit (MORU): Thailand-based tropical medicine research unit with deep infectious disease research, clinical trials, and diagnostics. Directly comparable in regional infectious disease research and public health laboratory mandate in Southeast Asia.
  • Institut Pasteur de Madagascar: Pasteur Network institute in a similarly resource-constrained developing country, operating medical biology labs, vaccination centers, and outbreak response. Directly comparable in scope, funding model, and service mix.
  • Institut Pasteur du Laos: Sister Pasteur Network institute in neighboring Laos, with a near-identical mandate of infectious disease research, public health laboratory services, and vaccination. Closest geographic and operational peer to IPC.

Emerging players

  • National Institute of Public Health (Cambodia): Cambodia's domestic public health agency, which collaborated directly with IPC during the COVID-19 pandemic for sample analysis. Adjacent in public health laboratory mission within the same geography.

Peers

  • Foundation for Innovative New Diagnostics (FIND): Global non-profit focused on diagnostic access in low- and middle-income countries. Operates in the same infectious disease diagnostics ecosystem and frequently partners with Pasteur Network institutes on capacity building and surveillance programs.

Broad incumbents

  • London School of Hygiene & Tropical Medicine: Global leader in tropical medicine and public health research, with comparable infectious disease and epidemiology research scope. Larger and broader, but overlapping mandate in global health research and training.
  • Institut Pasteur (Paris): Parent and headquarters of the Pasteur Network. Operates a much larger research portfolio globally, including vaccine R&D, but shares the Pasteurian values, ethical charter, and scientific oversight framework that governs IPC.

Regional players

  • Eijkman Institute for Molecular Biology: Indonesian infectious disease and molecular biology research institute. Comparable in regional infectious disease research, pathogen genomics, and tropical disease focus, though serving a different national market.
  • Sihanouk Hospital Center of HOPE: Phnom Penh-based hospital providing medical services and training in Cambodia. Adjacent peer in domestic Cambodian healthcare delivery, with overlapping referral and laboratory relationships with IPC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Institut Pasteur du Cambodge social profiles

Digital presence

Institut Pasteur du Cambodge financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Institut Pasteur du Cambodge leadership team

Management profile

Number of profiles

Profiles4 records

Institut Pasteur du Cambodge funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Institut Pasteur du Cambodge M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institut Pasteur du Cambodge

What does Institut Pasteur du Cambodge do?

Institut Pasteur du Cambodge operates as a non-profit research institution delivering fee-for-service medical biology laboratory testing, international vaccination services, food and water safety analysis, rabies post-exposure prophylaxis, calibration services, and HIV voluntary counseling and testing. It also conducts infectious disease research across six research units (virology, immunology, malaria, entomology, epidemiology and public health, and antimicrobial resistance), serving individual patients, hospitals, NGOs, and the Royal Government of Cambodia.

Is Institut Pasteur du Cambodge a public or private company?

Institut Pasteur du Cambodge is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Institut Pasteur du Cambodge founded?

Institut Pasteur du Cambodge was founded in 1953.

Where is Institut Pasteur du Cambodge based?

Institut Pasteur du Cambodge is headquartered in Phnom Penh, Cambodia, in the Asia region.

How does Institut Pasteur du Cambodge make money?

Five revenue lines are on record. Medical Laboratory Testing Services are the primary driver. The others are international Vaccination Center, food and Water Safety Testing, rabies Prevention Services and research Grants and Public Funding.

Who are Institut Pasteur du Cambodge's main competitors?

Direct peers on record are Institut Pasteur de Dakar, Mahidol Oxford Tropical Medicine Research Unit (MORU), Institut Pasteur de Madagascar and Institut Pasteur du Laos. National Institute of Public Health (Cambodia) is listed as an emerging player. Foundation for Innovative New Diagnostics (FIND) is listed as a peer. Broad incumbents are London School of Hygiene & Tropical Medicine and Institut Pasteur (Paris). Regional players are Eijkman Institute for Molecular Biology and Sihanouk Hospital Center of HOPE.

Does Institut Pasteur du Cambodge have an API?

No public API is recorded for Institut Pasteur du Cambodge.

What industry is Institut Pasteur du Cambodge in?

Institut Pasteur du Cambodge's product category is Medical Diagnostic Laboratory Services. Its primary akta.pro industry code is BPAIAJAF, Public Health Laboratories & Diagnostic Oversight, with a secondary code of HLAIAEAM, Vaccine Clinical Development & Regulatory Affairs. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NatureEvaluation of one year immunity following rabies post-exposure prophylaxis in dog bite casesA study of 148 patients receiving the Institut Pasteur du Cambodge rabies PEP regimen found that neutralizing antibodies persisted above protective levels in 87% of individuals one year after vaccination. T cell responses to rabies peptides were also sustained for a year, with no significant differences between those bitten by rabid and non-rabid dogs.PR Newswire3DMed Diagnostics doa suprimentos médicos para apoiar combate à COVID-19 no Camboja3DMed Diagnostics, a Shanghai-based biotechnology company, donated medical equipment worth $218,000 to Cambodia's Ministry of Health on September 3, 2021, to support the country's COVID-19 response. The donation includes automated sample preparation workstations, nucleic acid extraction systems, RT-qPCR instruments, and rapid test kits capable of detecting the Delta variant and other variants of concern. The company is collaborating with Institut Pasteur du Cambodge to improve laboratory efficiency, with its rapid testing solutions reducing result times from 4-5 hours to 70 minutes.PR Newswire3DMed Diagnostics fait don d'équipements médicaux au Cambodge pour l'aider à lutter contre la COVID-193DMed Diagnostics, a Shanghai-based biotechnology company, donated medical equipment worth over 184,000 euros (218,000 US dollars) to Cambodia's Ministry of Health on September 3, 2021, via videoconference, to support the country's COVID-19 response. The donation includes automated workstations, nucleic acid extraction systems, PCR instruments, and testing kits capable of detecting the Delta variant and other WHO-designated variants of concern. In collaboration with the Institut Pasteur du Cambodge, the equipment aims to reduce testing turnaround time from 4-5 hours to 70 minutes, enabling large-scale screening in a country facing a surge in Delta variant cases.PR Newswire3DMed Diagnostics dona suministros médicos para apoyar la lucha contra la COVID-19 en Camboya3DMed Diagnostics, a Shanghai-based biotechnology company, donated USD 218,000 worth of medical devices and COVID-19 testing equipment to Cambodia's Ministry of Health on September 3, 2021. The donation includes automated nucleic acid extraction systems, RT-qPCR instruments, and rapid test kits capable of detecting the delta variant and all WHO-identified variants of concern, reducing testing time from 4-5 hours to 70 minutes. The company is collaborating with Institut Pasteur du Cambodge to improve laboratory testing efficiency as Cambodia faces rising delta variant cases.